Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2021-03-01 RUBINSTEIN JULIE President Option exercise +15,000 $6.55 $98K 15,000
2021-03-01 RUBINSTEIN JULIE President Sale −4,684 $57.54 $270K 10,316
2021-03-01 RUBINSTEIN JULIE President Sale −9,471 $58.64 $555K 845
2021-03-01 RUBINSTEIN JULIE President Sale −845 $58.99 $50K 0
2021-03-01 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −15,000 225,325
2021-03-01 BENZENO SHARON Chief Business Development Off Option exercise +2,604 $6.55 $17K 2,604
2021-03-01 BENZENO SHARON Chief Business Development Off Option exercise +2,604 $6.55 $17K 5,208
2021-03-01 BENZENO SHARON Chief Business Development Off Option exercise +1,563 $7.27 $11K 6,771
2021-03-01 BENZENO SHARON Chief Business Development Off Sale −6,210 $57.57 $358K 561
2021-03-01 BENZENO SHARON Chief Business Development Off Sale −561 $58.17 $33K 0
2021-03-01 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −2,604 20,834
2021-03-01 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −2,604 49,480
2021-03-01 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −1,563 34,375
2021-03-01 Pellini Michael J Director Option exercise +20,000 $6.55 $131K 20,000
2021-03-01 Pellini Michael J Director Sale −20,000 $57.80 $1.2M 0
2021-03-01 Pellini Michael J Director Option exercise · Stock Option (Right to Buy) −20,000 55,000
2021-02-26 RUBINSTEIN JULIE President Option exercise +15,000 $6.55 $98K 15,000
2021-02-26 RUBINSTEIN JULIE President Sale −15,000 $56.23 $843K 0
2021-02-26 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −15,000 240,325
2021-02-26 Taylor Stacy L SVP and General Counsel Option exercise +1,041 $7.80 $8K 2,341

Page 56 of 120 · 2,386 trades